Ipamorelin
Ipamorelin is a selective growth hormone releasing peptide (GHRP) that stimulates natural growth hormone production from the pituitary gland.
Also known as: Growth Hormone Secretagogue, Selective GHRP
Overview
Ipamorelin is a selective growth hormone releasing peptide (GHRP) that stimulates natural growth hormone production from the pituitary gland. Known for its clean profile with minimal side effects on cortisol and prolactin levels, making it ideal for body composition, recovery, and anti-aging applications.
Key Benefits
- Natural GH Stimulation
- IGF-1 Enhancement
- Anti-Aging Benefits
Optimal growth hormone stimulation with precise dosing and superior bioavailability. Most effective method for body composition, recovery, and anti-aging applications with minimal side effects.
Mechanism of Action
Injectable Ipamorelin provides direct systemic delivery for consistent GH pulse stimulation. Binds selectively to ghrelin receptors in the pituitary to stimulate natural GH release without affecting cortisol, prolactin, or causing significant hunger.
Pharmacokinetics
Peak plasma concentration: 40 min. Elimination half-life: 2 hrs. Largely cleared by: ~10 hrs.
Research Protocols Injectable
| Goal | Dose | Frequency | Route |
|---|---|---|---|
| General Health & Longevity | 200mcg | 1x daily before bed | Subcutaneous |
| Body Composition | 250-300mcg | 2x daily (morning, pre-workout) | Subcutaneous |
| Athletic Performance | 200-250mcg | 2-3x daily (morning, pre/post workout) | Subcutaneous |
| Sleep & Recovery | 200mcg | 1x daily 30min before bed | Subcutaneous |
| Anti-Aging Protocol | 200-250mcg | 1-2x daily (morning, bedtime) | Subcutaneous |
Research protocols from published literature — not dosing recommendations.
Peptide Interactions
- CJC-1295 — Synergistic: Gold standard combination - CJC extends GH release while Ipamorelin provides the pulse for optimal growth hormone cycles
- BPC-157 — Synergistic: BPC-157 upregulates GH receptors, potentially enhancing Ipamorelin effectiveness for recovery and muscle growth
- TB-500 — Compatible: Complementary for muscle recovery, tissue repair, and overall regeneration
- Sermorelin — Synergistic: Excellent combination - Sermorelin (GHRH) and Ipamorelin (GHRP) work through different receptor pathways, producing synergistic 3-5 fold increases in GH release
- GHRP-2 — Avoid Combination: Redundant GH stimulation pathways, may cause receptor desensitization
- GHRP-6 — Avoid Combination: Similar mechanism with higher hunger effects, stick to Ipamorelin for cleaner profile
- Tesamorelin — Monitor Combination: Synergistic GH stimulation possible. Monitor IGF-1 levels closely and consider dose adjustments to prevent excessive growth hormone elevation.
Peptide Instructions Injectable
Supplies:
- Bacteriostatic water (BAC water)
- Insulin syringes (0.5-1mL, 29-31 gauge)
- Alcohol swabs
- Ipamorelin peptide vial
- Sterile work surface
How to Reconstitute Injectable
- 1Clean work area and hands thoroughly with antibacterial soap
- 2Gather all materials and let refrigerated peptide reach room temperature
- 3Calculate required BAC water volume using the calculator below
- 4Draw calculated BAC water amount into syringe
- 5Inject BAC water slowly down the side of vial (never directly onto powder)
- 6Gently swirl vial until completely dissolved (never shake vigorously)
- 7Store reconstituted solution in refrigerator, use within 28 days
What to Expect Injectable
Week 1-2: Improved sleep quality, deeper sleep, better morning energy. Week 2-4: Enhanced recovery from exercise, reduced muscle soreness. Week 4-8: Body composition improvements, increased lean mass, fat loss. Week 8-12: Continued improvements in muscle tone, skin quality, energy. Side effects: Minimal, occasional mild hunger 20-30 minutes post-injection. Most effective for: Sleep optimization, body recomposition, anti-aging.
Side Effects & Safety
Use sterile injection technique to prevent infection. May cause mild hunger increase 20-30 minutes post-injection. Monitor for receptor desensitization after 3-4 months of continuous use. Cycle off periodically to maintain effectiveness and receptor sensitivity. Not recommended during pregnancy, breastfeeding, or active cancer.
Use sterile injection technique to prevent infection. May cause mild hunger increase 20-30 minutes post-injection. Monitor for receptor desensitization after 3-4 months of continuous use. Cycle off periodically to maintain effectiveness and receptor sensitivity. Not recommended during pregnancy, breastfeeding, or active cancer.
Community Insights
Ipamorelin should be stored at Refrigerate 2-8°C, use within 28 days after reconstitution.
Molecular Information
References
- Safety and Tolerability Analysis (2023)
- Athletic Performance Study (2022)
- Sleep Quality Research (2021)
- Body Composition Clinical Trial (2020)
- Growth Hormone Stimulation Study (2019)
Research reference only. Not medical advice.